BR9816021A - Derivados de ácido alfa-(1-piperazinil) acetamido areno carboxilìco como agentes antidiabéticos - Google Patents

Derivados de ácido alfa-(1-piperazinil) acetamido areno carboxilìco como agentes antidiabéticos

Info

Publication number
BR9816021A
BR9816021A BR9816021-4A BR9816021A BR9816021A BR 9816021 A BR9816021 A BR 9816021A BR 9816021 A BR9816021 A BR 9816021A BR 9816021 A BR9816021 A BR 9816021A
Authority
BR
Brazil
Prior art keywords
alpha
acid derivatives
acetamido
piperazinyl
carboxylic acid
Prior art date
Application number
BR9816021-4A
Other languages
English (en)
Inventor
Gerard Botton
Gerard Patereau
Liliane Doare
Micheline Kergoat
Didier Mesangeau
Donald D Bierer
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR9816021A publication Critical patent/BR9816021A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"DERIVADOS DE áCIDO ALFA -(1-PIPERAZINIL) ACETAMIDO ARENO CARBOXìLICO COMO AGENTES ANTIDIABéTICOS"<D>. A invenção refere-se a compostos de fórmula genérica (I). Estes compostos são úteis no tratamento de diabetes.
BR9816021-4A 1997-05-13 1998-06-08 Derivados de ácido alfa-(1-piperazinil) acetamido areno carboxilìco como agentes antidiabéticos BR9816021A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705849A FR2763334A1 (fr) 1997-05-13 1997-05-13 Derives anthraniliques
PCT/EP1998/003431 WO1999064407A1 (en) 1997-05-13 1998-06-08 α-(1-PIPERAZINYL)ACETAMIDO ARENECARBOXYLIC ACID DERIVATIVES AS ANTIDIABETIC AGENTS

Publications (1)

Publication Number Publication Date
BR9816021A true BR9816021A (pt) 2001-05-15

Family

ID=26070316

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9816021-4A BR9816021A (pt) 1997-05-13 1998-06-08 Derivados de ácido alfa-(1-piperazinil) acetamido areno carboxilìco como agentes antidiabéticos

Country Status (4)

Country Link
CN (1) CN1119338C (pt)
BR (1) BR9816021A (pt)
FR (1) FR2763334A1 (pt)
WO (1) WO1999064407A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA00011889A (es) 1998-06-02 2003-04-25 Osi Pharm Inc Composiciones de pirrolo (2,3d) piridina y su uso.
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
JO2390B1 (en) 2001-04-06 2007-06-17 شركة جانسين فارماسوتيكا ان. في Diphenylcarboxamides act as lipid-lowering agents
EP1450811B1 (en) 2001-11-30 2009-10-21 OSI Pharmaceuticals, Inc. Compounds specific to adenosine A1 and A3 receptors and uses thereof
CN1620294A (zh) * 2001-12-20 2005-05-25 Osi药物公司 嘧啶a2b选择性拮抗剂化合物,它们的合成及用途
AR042067A1 (es) * 2002-11-27 2005-06-08 Bayer Pharmaceuticals Corp Derivados de anilinopirazol utiles en el tratamiento de la diabetes
CN100448869C (zh) * 2002-11-27 2009-01-07 拜尔药品公司 用于治疗糖尿病的苯胺基吡唑衍生物
GB0319124D0 (en) * 2003-08-14 2003-09-17 Smithkline Beecham Corp Chemical compounds
JP2008530074A (ja) * 2005-02-14 2008-08-07 スミスクライン・ビーチャム・コーポレイション Ｈｍ７４ａ受容体アゴニストとしてのアントラニル酸誘導体
CN103804362A (zh) * 2012-11-12 2014-05-21 韩文毅 一类治疗糖尿病的化合物及其用途
IL277071B1 (en) 2018-03-08 2024-03-01 Incyte Corp Aminopyrizine diol compounds as PI3K–y inhibitors
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
US11871772B2 (en) * 2018-08-10 2024-01-16 Firmenich Incorporated Antagonists of T2R54 and compositions and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
FR2674522B1 (fr) * 1991-03-26 1993-07-16 Lipha Nouveaux derives de l'indole, procedes de preparation et medicaments les contenant.
FR2693722B1 (fr) * 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
WO1996026924A1 (fr) * 1995-02-28 1996-09-06 Suntory Limited Derives d'arylpiperidine et d'arylpiperazine et medicaments contenant lesdits derives
FR2757158B1 (fr) * 1996-12-18 1999-04-02 Lipha Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques

Also Published As

Publication number Publication date
FR2763334A1 (fr) 1998-11-20
CN1119338C (zh) 2003-08-27
WO1999064407A1 (en) 1999-12-16
CN1301259A (zh) 2001-06-27

Similar Documents

Publication Publication Date Title
BR9816021A (pt) Derivados de ácido alfa-(1-piperazinil) acetamido areno carboxilìco como agentes antidiabéticos
TR200401029T4 (tr) Asilfenil-üre türevleri, imalat yöntemleri ve ilaç maddesi olarak kullanımları
TR199902538T2 (xx) Yeni bile�imler.
AU1973997A (en) Pentafluorobenzenesulfonamides and analogs
WO2001019776A3 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
CA2368347A1 (en) Glucokinase activators
IL162498A (en) Alpha-(n-sulphonamido) acetamide derivatives and pharmaceutical compositions containing the same
CA2216796A1 (en) Quinazoline derivatives
TR200001816T2 (tr) Hipolipidemik benzotiyazepin bileşikleri
YU70901A (sh) Derivati 1,4-benzotiazepin-1,1 dioksida zamenjeni radikalima šećera, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena
ES2101421T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
ES8802381A1 (es) Procedimiento para la obtencion de n-indolitelil-sulfonamidas
NO940506D0 (no) Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater
TR199900486T2 (xx) Aziniloksi ve fenoksi-diaril-karbonasit t�revleri.
IS4553A (is) Lyfjablöndur sem innihalda mónóamín oxídasa B blokkara
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
TR199902094T2 (xx) 3-Heteroareil-4(3H)-kinazolinonlar�n atropizomerleri.
ES2194102T3 (es) Nuevas n-(2,4-dioxo-2,3,4,5-tetrahidro-1h-1,5-benzodiazepin-3-il)-3-amidas.
DE60107832D1 (en) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
ATE157660T1 (de) Hydroxymethylfurazancarbonsäurederivate und ihre verwendung in der behandlung von kardiovaskulären erkrankungen
ES2123728T3 (es) Derivados de pirrolo-pirazina de actividad 5-ht3.
NO20043286L (no) Piperidinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
PT1194398E (pt) Sintese de aminocarnitina (s) e (r) e dos seus derivados, a partir de acido aspartico l e d
TR200001122T2 (tr) Farmasötikler olarak bifenil türevleri.

Legal Events

Date Code Title Description
HHX Correction

Free format text: REFERENTE A RENUMERACAO PUBLICADA NA RPI 1579 DE 10/04/2001 SOB O NUMERO PI0005805-0 UMA VEZ QUE A DATA DE DEPOSITO CORRETA E 08/06/98

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7,8 E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1910 DE 14/08/2007.